Description (404ae0dd 9a7d 4199 9647 D7c6b9d3c281 01)
Sevelamer Carbonate Tablet
Product Images NDC 64380-872
View Photos of Packaging, Regulatory Labels, and Product Appearance
Product Visual Gallery
This gallery contains 6 technical images submitted to the FDA as part of the official labeling for Sevelamer Carbonate (NDC 64380-872). Unlike standard consumer photos, these assets often include clinical data figures, molecular chemical structures, and official manufacturer packaging layouts.
As provided by Strides Pharma Science Limited, these visuals offer a comprehensive scientific overview of the product's physical and chemical identity, aiding pharmacists and researchers in product verification and study.
Figure-2 (404ae0dd 9a7d 4199 9647 D7c6b9d3c281 02)
Figure 2 (404ae0dd 9a7d 4199 9647 D7c6b9d3c281 03)
This description provides information on the percentage of patients with reduction in serum phosphorus levels after treatment with Sevelamer Hydrochloride compared to an active control. The chart displays the reductions from baseline, assessing improvement or worsening of serum phosphorus levels. The X value mentioned in the text likely indicates a specific threshold for reduction.*
Image (404ae0dd 9a7d 4199 9647 D7c6b9d3c281 04)
Container Label (30S)
Each film-coated tablet contains 800 mg of the active ingredient Sevelamer carbonate, along with other ingredients like crospovidone, microcrystalline cellulose, and magnesium stearate. It is recommended to store the tablets in a tight container at 25°C and protect them from moisture. The usual dosage instructions are provided in the package insert. This medication is manufactured by Sirdes Pharma Science Ltd. in Puducherry, India, and distributed by Sirides Pharma Inc. in East Brunswick, NJ 08816.*
Container Label 270s (404ae0dd 9a7d 4199 9647 D7c6b9d3c281 06)
This is a description of a film-coated tablet containing 800 mg of Sevelamer carbonate as the active ingredient. The tablet also includes inactive ingredients such as colloidal silicon dioxide, crospovidone, microcrystalline cellulose, magnesium stearate, and various other components. The manufacturing information indicates that the tablets are produced by Strides Pharma Science Ltd. in Puducherry, India, and distributed by Strides Pharma Inc. in East Brunswick, NJ. It is advised to store the tablets at 25°C (77°F) with excursions permitted between 15-30°C (59-86°F) and protect them from moisture. Additionally, the usual dosage and other relevant information are likely included in the package insert which should be consulted.*
* These product label images have been analyzed using experimental machine learning. Please verify findings with the primary label text.
